A detailed history of Saturn V Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Saturn V Capital Management LLC holds 178,589 shares of BMRN stock, worth $11.9 Million. This represents 5.56% of its overall portfolio holdings.

Number of Shares
178,589
Previous 119,188 49.84%
Holding current value
$11.9 Million
Previous $10.4 Billion 41.24%
% of portfolio
5.56%
Previous 4.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$74.43 - $92.22 $4.42 Million - $5.48 Million
59,401 Added 49.84%
178,589 $14.7 Billion
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $724,318 - $936,140
9,503 Added 8.66%
119,188 $11.5 Billion
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $1.45 Million - $1.61 Million
17,059 Added 18.42%
109,685 $9.7 Billion
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $8.03 Million - $9.29 Million
92,626 New
92,626 $8.03 Billion

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.